世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2014年
5期
623-626
,共4页
赵轩%高彦彬%周盛楠%李娇阳%朱智耀%张娜
趙軒%高彥彬%週盛楠%李嬌暘%硃智耀%張娜
조헌%고언빈%주성남%리교양%주지요%장나
胰岛素抵抗%糖脂平%糖脂代谢%胰岛素敏感性
胰島素牴抗%糖脂平%糖脂代謝%胰島素敏感性
이도소저항%당지평%당지대사%이도소민감성
Insulin Resistance%Tangzhiping%Glucose and lipid metabolism%Insulin sensitivity
目的:建立喂养型胰岛素抵抗( IR)大鼠模型,观察糖脂平对喂养型IR大鼠糖脂代谢的影响。方法:选用体重在180~200 g的8周龄雄性SD大鼠60只,适应性喂养1周后,随机分为空白对照组15只和造模组45只。空白对照组采用普通饲料喂养,造模组采用高脂饲料喂养。8周造模成功后,将造模组随机分为:模型组、糖脂平组、罗格列酮组各15只。糖脂平组给予糖脂平按生药20 g/( kg· d)灌胃;罗格列酮组给予罗格列酮0.8 mg/( kg· d)灌胃;模型组和空白对照组灌服等量的生理盐水;末次给药后禁食12 h,用正常血糖胰岛素钳夹技术来评价胰岛素敏感性,并检测各组大鼠的体重、血糖、血清胰岛素、血脂( TG、TC、HDL-C、LDL-C)等指标。结果:糖脂平能够增加胰岛素敏感性,改善胰岛素抵抗,抑制体重增长,效果优于罗格列酮;同时可降低血糖、空腹血清胰岛素,降低TG和LDL-c,与罗格列酮药效相近。结论:糖脂平能够调整IR大鼠的糖脂代谢紊乱,改善胰岛素抵抗。
目的:建立餵養型胰島素牴抗( IR)大鼠模型,觀察糖脂平對餵養型IR大鼠糖脂代謝的影響。方法:選用體重在180~200 g的8週齡雄性SD大鼠60隻,適應性餵養1週後,隨機分為空白對照組15隻和造模組45隻。空白對照組採用普通飼料餵養,造模組採用高脂飼料餵養。8週造模成功後,將造模組隨機分為:模型組、糖脂平組、囉格列酮組各15隻。糖脂平組給予糖脂平按生藥20 g/( kg· d)灌胃;囉格列酮組給予囉格列酮0.8 mg/( kg· d)灌胃;模型組和空白對照組灌服等量的生理鹽水;末次給藥後禁食12 h,用正常血糖胰島素鉗夾技術來評價胰島素敏感性,併檢測各組大鼠的體重、血糖、血清胰島素、血脂( TG、TC、HDL-C、LDL-C)等指標。結果:糖脂平能夠增加胰島素敏感性,改善胰島素牴抗,抑製體重增長,效果優于囉格列酮;同時可降低血糖、空腹血清胰島素,降低TG和LDL-c,與囉格列酮藥效相近。結論:糖脂平能夠調整IR大鼠的糖脂代謝紊亂,改善胰島素牴抗。
목적:건립위양형이도소저항( IR)대서모형,관찰당지평대위양형IR대서당지대사적영향。방법:선용체중재180~200 g적8주령웅성SD대서60지,괄응성위양1주후,수궤분위공백대조조15지화조모조45지。공백대조조채용보통사료위양,조모조채용고지사료위양。8주조모성공후,장조모조수궤분위:모형조、당지평조、라격렬동조각15지。당지평조급여당지평안생약20 g/( kg· d)관위;라격렬동조급여라격렬동0.8 mg/( kg· d)관위;모형조화공백대조조관복등량적생리염수;말차급약후금식12 h,용정상혈당이도소겸협기술래평개이도소민감성,병검측각조대서적체중、혈당、혈청이도소、혈지( TG、TC、HDL-C、LDL-C)등지표。결과:당지평능구증가이도소민감성,개선이도소저항,억제체중증장,효과우우라격렬동;동시가강저혈당、공복혈청이도소,강저TG화LDL-c,여라격렬동약효상근。결론:당지평능구조정IR대서적당지대사문란,개선이도소저항。
Objective:To investigate the effects of Tangzhiping on glucose and lipid metabolism in rats with insulin resistance .Meth-ods:Sixty male SD rats which were 8 weeks old and weighted among 180 to 200 g were randomly divided into blank control group ( n=15) and module group (n=45) after being fed for a week for adaptation .Rats in the blank control group were fed with common food , while module group fed the rats with high fat food for 8 weeks.Eight weeks later, the model rats were successfully made , and they were randomly divided into:the model group (n=15), Tangzhiping group (n=15), rosiglitazone group (n=15).Tangzhiping group gave the rats Tangzhiping formula particles according to the statement 20 g/kg/d to fill in the stomach;rosiglitazone group applied up to 0.8 mg/kg/d rosiglitazone gavage;model group and blank control group used the same amount of saline solution for 8weeks.Twelve hours after the last administration , levels of insulin sensitivity was evaluated by the “euglycemic hyperinsulin clamp technique”, and levels of body weight, fast plasma glucose, serum insulin, blood lipids were also observed .Results:Tangzhiping could raise insulin sensitivity , improve IR, suppress weight gain which was better than rosiglitazone;it could lower blood sugar, reduce serum insulin, TG and LDL-c, which was close to the efficacy of rosiglitazone .Conclusion: IR model is successfully established .Tangzhiping and rosiglitazone can lose weight , reduce blood sugar and insulin levels , adjust blood lipid levels and increase insulin sensitivity .